Previous Close | 5.50 |
Open | 5.79 |
Bid | 5.21 x 1000 |
Ask | 6.16 x 1200 |
Day's Range | 5.31 - 5.79 |
52 Week Range | 5.07 - 14.80 |
Volume | |
Avg. Volume | 4,283 |
Market Cap | 136.403M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 6.67 |
EPS (TTM) | 0.87 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MHUA
Didi’s Wall Street ride came to an end less than a year after it began. Just 11-months after making a splash in a $4.4 billion IPO, shareholders made official Monday what has long been considered inevitable, approving a plan to delist its shares from the New York Stock Exchange. While Didi’s shares are formally expected to be delisted next month, Bernstein, who consults Chinese firms looking to list in the U.S, said the ramifications from its tumultuous journey is likely to hang over other firms eyeing an American listing.
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on May 18, 2022, it received notice from The Nasdaq Stock Market ("Nasdaq") that, because the Company has not yet filed its annual report on Form 20-F for the year ended December 31, 2021, the Company is out of compliance with the Nasdaq rules for continued
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced the closing of its initial public offering (the "Offering") of 3,940,000 ordinary shares at a public offering price of $10.00 per ordinary share (the "Ordinary Shares") which includes 340,000 Ordinary Shares issued pursuant to the partial exercise of the underwri